51³ΙΘΛΆ―Βώ

Meeting Coverage

ASCO Future Focus: Endometrial Cancer

Future Focus from the American Society of Clinical Oncology

The 'Four Buckets' of Breakthroughs in Endometrial Cancer

Richard Penson breaks down the future landscape into four categories

image

Latest ASCO Future Focus: Endometrial Cancer Meeting Coverage

A Changing Landscape in First-Line Endometrial Cancer

FDA must decide whether to approve checkpoint inhibitors for all patients, says Alessandro Santin

July 5, 2023
Three Areas of Promise in Endometrial Cancer

Bobbie J. Rimel gives insight into what she is most looking forward to in this treatment space

June 27, 2023
PROs Support Practice-Changing RUBY Trial in Endometrial Cancer

Adding dostarlimab upfront does not add significant toxicity for patients, says Pamela Soliman

June 20, 2023

Latest Oncology/Hematology Meeting Coverage